This web site has been relocated. Please visit www2.cscc.unc.edu/spiromics
Subpopulations and intermediate outcome measures in COPD study Logo Subpopulations and intermediate outcome measures in COPD study Logo
About the Study -> About SPIROMICS
About SPIROMICS Site Listing Locations Ancillary Studies Public Manuals & Docs Publications
All Personnel By Site By Title By Committee Committee Membership Search Email to Groups Email to All
Search Site Contents Calendar Agendas/Minutes Meeting Materials Protocols and Manuals Forms Reports Other Documents Publications Hub Manuscripts Abstracts Study Presentations Photos GIC Info
ESB Documents
OSMB Documents
GIC Info
Subpopulations and intermediate outcome measures in COPD study (SPIROMICS) supports the prospective collection and analysis of phenotypic, biomarker, genetic, genomic, and clinical data from subjects with COPD for the purpose of identifying subpopulations and intermediate outcome measures. It is funded by the National Heart, Lung, and Blood Institute and is coordinated by the University of North Carolina at Chapel Hill.

Research subjects for SPIROMICS will be enrolled, phenotyped, and followed at six SPIROMICS Clinical Centers (in Winston-Salem, NC; Ann Arbor, MI; San Francisco, CA; Los Angeles, CA; New York City, NY; and Salt Lake City, UT). Molecular fingerprinting and extensive subject phenotyping will be performed to identify disease subpopulations and to identify and validate surrogate markers of disease severity which will be useful as intermediate outcome measures for future clinical trials. Secondary aims are to clarify the natural history of COPD, to develop bioinformatic resources that will enable the utilization and sharing of data in studies of COPD and related diseases, and to create a collection of clinical, biomarker, radiographic, and genetic data that can be used by external investigators for other studies of COPD.